Cargando…

Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators

Engineered CRISPR/Cas9-based transcriptional activators can potently and specifically activate endogenous fate-determining genes to direct differentiation of pluripotent stem cells. Here, we demonstrate that endogenous activation of the PAX7 transcription factor results in stable epigenetic remodeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Jennifer B., Vankara, Ashish, Ettyreddy, Adarsh R., Bohning, Joel D., Gersbach, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221109/ https://www.ncbi.nlm.nih.gov/pubmed/32330446 http://dx.doi.org/10.1016/j.stemcr.2020.03.026

Ejemplares similares

In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
por: Kwon, Jennifer B., et al.
Publicado: (2020)

A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification
por: Chakraborty, Syandan, et al.
Publicado: (2014)

RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
por: Thakore, Pratiksha I., et al.
Publicado: (2018)

Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators
por: Wang, Jianglin, et al.
Publicado: (2020)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

A light-inducible CRISPR/Cas9 system for control of endogenous gene activation
por: Polstein, Lauren R., et al.
Publicado: (2015)

CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy
por: Domenig, Seraina A., et al.
Publicado: (2022)

RNA-guided gene activation by CRISPR-Cas9-based transcription factors
por: Perez-Pinera, Pablo, et al.
Publicado: (2013)

Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9
por: Higashioka, Koki, et al.
Publicado: (2017)

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
por: Kabadi, Ami M., et al.
Publicado: (2014)

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators
por: Polstein, Lauren R., et al.
Publicado: (2015)

Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements
por: Thakore, Pratiksha I., et al.
Publicado: (2015)

Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription Factors
por: Matjusaitis, Mantas, et al.
Publicado: (2019)

Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy
por: Ousterout, David G., et al.
Publicado: (2015)

Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain
por: Kabadi, Ami M., et al.
Publicado: (2014)

Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers
por: Hilton, Isaac B., et al.
Publicado: (2015)

Single-cell lineage tracing by integrating CRISPR-Cas9 mutations with transcriptomic data
por: Zafar, Hamim, et al.
Publicado: (2020)

CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells
por: Mandl, Markus, et al.
Publicado: (2020)

Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells
por: Pickar-Oliver, Adrian, et al.
Publicado: (2019)

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
por: Klann, Tyler S., et al.
Publicado: (2017)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
por: Lee, Jounghyun H., et al.
Publicado: (2023)

Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter
por: Dicks, Amanda, et al.
Publicado: (2020)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
por: Dastidar, Sumitava, et al.
Publicado: (2018)

Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
por: Shakirova, Ksenia M., et al.
Publicado: (2020)

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
por: Brunetti, Lorenzo, et al.
Publicado: (2018)

Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2019)

Programmable CRISPR‐Cas transcriptional activation in bacteria
por: Ho, Hsing‐I, et al.
Publicado: (2020)

SIX1(+)PAX3(+) identify a progenitor for myogenic lineage commitment from hPSCs
por: Jaime, Olga G., et al.
Publicado: (2023)

Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma
por: Butler, Erin, et al.
Publicado: (2022)

Simultaneous lineage tracing and cell-type identification using CRISPR/Cas9-induced genetic scars
por: Spanjaard, Bastiaan, et al.
Publicado: (2018)

Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
por: Aschenbrenner, Sabine, et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients
por: Provenzano, Claudia, et al.
Publicado: (2017)

Increasing the specificity of CRISPR systems with engineered RNA secondary structures
por: Kocak, D. Dewran, et al.
Publicado: (2019)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Genetic Analysis Based on CRISPR/Cas9 Technology in Plants
por: Kang, Kwon-Kyoo, et al.
Publicado: (2023)

Comparison of CRISPR–Cas9 Tools for Transcriptional Repression and Gene Disruption in the BEVS
por: Bruder, Mark R., et al.
Publicado: (2021)

Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR‐Cas9 screen
por: Mennuni, Mara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4lcl1kgku2vf0bhicdlgdqrgi